Sunflower Pharmaceutical GroupLtd Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Yi Guan

İcra Kurulu Başkanı

CN¥4.8m

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	5.8yrs
CEO sahipliği	n/a
Yönetim ortalama görev süresi	2.9yrs
Yönetim Kurulu ortalama görev süresi	3.4yrs

Son yönetim güncellemeleri

Recent updates

CEO

Yi Guan (42 yo)

5.8yrs

Görev süresi

CN¥4,800,000

Tazminat

Ms. Yi Guan has been a Non-Independent Director of Sunflower Pharmaceutical Group Co., Ltd. since September 26, 2017 and serves as its General Manager since January 07, 2019. She was awarded the title of H...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Yi Guan	GM & Non-Independent Director	5.8yrs	CN¥4.80m	Veri yok
Chunhong Wu	Financial Manager	2.9yrs	CN¥774.90k	Veri yok
Guangguang Zhou	Board Secretary	2.8yrs	CN¥436.70k	Veri yok
Liang Chen	Deputy General Manager	2.9yrs	CN¥3.06m	Veri yok
Jin Ming Lin	Deputy General Manager	4.8yrs	CN¥786.00k	Veri yok
Xin Ma	Deputy General Manager	2.9yrs	CN¥1.36m	Veri yok
Yang Hai	Deputy General Manager	2.9yrs	CN¥1.41m	Veri yok

2.9yrs

Ortalama Görev Süresi

43yo

Ortalama Yaş

Deneyimli Yönetim: 002737 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.9 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Yi Guan	GM & Non-Independent Director	7.2yrs	CN¥4.80m	Veri yok
Yanling Guan	Non-Independent Director	10.7yrs	CN¥1.18m	Veri yok
Jingshang Ren	Non-Independent Director	7.2yrs	CN¥50.00k	Veri yok
Yan He	Non-Employee Supervisor	7.2yrs	Veri yok	Veri yok
Chunyan Na	Supervisor	4.1yrs	Veri yok	Veri yok
Yuxiu Guan	Chairman	5.8yrs	CN¥1.20m	Veri yok
Fen Lan	Chairman of the Supervisory Board	2.7yrs	Veri yok	Veri yok
Jianzhong Zhou	Non-Independent Director	less than a year	Veri yok	Veri yok
Yang Yang	Non-Independent Director	less than a year	Veri yok	Veri yok
Jiajun Miao	Independent Director	less than a year	Veri yok	Veri yok
Ying Zhang	Independent Director	less than a year	Veri yok	Veri yok
Yan Zhao	Independent director	less than a year	Veri yok	Veri yok

3.4yrs

Ortalama Görev Süresi

46yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 002737 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.4 yıldır).

Sunflower Pharmaceutical GroupLtd Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

High number of new directors

Sunflower Pharmaceutical Group Co.,Ltd Announces Board Appointments

Sunflower Pharmaceutical Group Co.,Ltd, Annual General Meeting, May 30, 2024

High number of new directors

High number of new directors

Sunflower Pharmaceutical Group Co.,Ltd, Annual General Meeting, May 13, 2022

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.17 (vs CN¥0.37 in 3Q 2023)

Investor sentiment deteriorates as stock falls 16%

Sunflower Pharmaceutical Group Co.,Ltd to Report Q3, 2024 Results on Oct 29, 2024

Investor sentiment improves as stock rises 17%

Second quarter 2024 earnings released: EPS: CN¥0.39 (vs CN¥0.40 in 2Q 2023)

Now 22% overvalued

High number of new directors

Sunflower Pharmaceutical Group Co.,Ltd to Report First Half, 2024 Results on Aug 28, 2024

Sunflower Pharmaceutical Group Co.,Ltd Announces Board Appointments

Investor sentiment deteriorates as stock falls 16%

Dividend increased to CN¥1.50

Sunflower Pharmaceutical Group Co.,Ltd Announces Final Cash Dividend (Tax Included) (A Shares) for the Year 2023, Payable on 14 June 2024

Sunflower Pharmaceutical Group Co.,Ltd, Annual General Meeting, May 30, 2024

Sunflower Pharmaceutical Group Co.,Ltd Announces Profit Distribution Proposal for 2023

First quarter 2024 earnings released: EPS: CN¥0.44 (vs CN¥0.70 in 1Q 2023)

Sunflower Pharmaceutical Group Co.,Ltd to Report Q1, 2024 Results on Apr 26, 2024

Sunflower Pharmaceutical Group Co.,Ltd to Report Fiscal Year 2023 Results on Apr 26, 2024

Third quarter 2023 earnings released: EPS: CN¥0.37 (vs CN¥0.18 in 3Q 2022)

Sunflower Pharmaceutical Group Co.,Ltd to Report Q3, 2023 Results on Oct 26, 2023

Second quarter 2023 earnings released: EPS: CN¥0.40 (vs CN¥0.32 in 2Q 2022)

Sunflower Pharmaceutical Group Co.,Ltd Announces Final Cash Dividend on Share A for 2022, Payable on June 7, 2023

Full year 2022 earnings released: EPS: CN¥1.48 (vs CN¥1.21 in FY 2021)

Now 20% undervalued

Now 22% undervalued after recent price drop

Now 21% undervalued

Now 21% undervalued

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Now 21% undervalued

Now 21% undervalued

Investor sentiment improved over the past week

High number of new directors

Third quarter 2022 earnings released: EPS: CN¥0.18 (vs CN¥0.16 in 3Q 2021)

Investor sentiment improved over the past week

Now 21% undervalued

High number of new directors

Now 20% undervalued

Second quarter 2022 earnings released: EPS: CN¥0.32 (vs CN¥0.14 in 2Q 2021)

Sunflower Pharmaceutical Group Co.,Ltd Announces 2021 Final Profit Distribution Plan to Be Implemented on A Shares, Payable on 02 June 2022

Sunflower Pharmaceutical Group Co.,Ltd Approves 2021 Profit Distribution Plan

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS: CN¥1.21 (vs CN¥1.00 in FY 2020)

Sunflower Pharmaceutical Group Co.,Ltd, Annual General Meeting, May 13, 2022

Sunflower Pharmaceutical Group Co.,Ltd Proposes Final Cash Dividend for the Year 2021

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.16 (vs CN¥0.14 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.15 in 2Q 2020)

Investor sentiment improved over the past week

Sunflower Pharmaceutical Group Co.,Ltd Approves Cash Dividend for the Year 2020

Full year 2020 earnings released: EPS CN¥1.00 (vs CN¥0.97 in FY 2019)

Sunflower Pharmaceutical Group Co.,Ltd to Report Fiscal Year 2020 Results on Apr 21, 2021

New 90-day low: CN¥12.98

New 90-day low: CN¥14.03

New 90-day low: CN¥14.53

Third quarter earnings released

Sunflower Pharmaceutical Group Co.,Ltd Announces Executive Appointments

New 90-day high - CN¥16.50

Earnings released

Sunflower Pharmaceutical Group Co.,Ltd to Report First Half, 2020 Results on Aug 26, 2020

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş